NeuroBo Pharmaceuticals, Inc.
NASDAQ:NRBO
2.36 (USD) • At close November 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -27.592 | -12.47 | -13.967 | -15.284 | -29.678 | -21.312 | -23.637 | -33.415 | -14.586 | -9.029 | -0.32 |
| Depreciation & Amortization
| 0.02 | 0.006 | 0.028 | 0.048 | 0.046 | 0.017 | 0.346 | 0.137 | -0.017 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 1.114 | -0.346 | -0.137 | -0.276 | 0 | 0 |
| Stock Based Compensation
| 0.538 | 0.222 | 0.854 | 0.001 | 0.001 | 0 | 4.131 | 5.273 | 1.718 | 0.284 | 0.053 |
| Change In Working Capital
| 0 | 4.397 | -1.168 | -0.584 | 0.809 | 0.744 | -2.751 | 1.104 | 1.918 | 1.446 | 0.017 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 3.058 | 0.113 | -0.202 | -1.162 | 1.123 | -1.046 | -1.981 | 2.007 | 1.477 | 0.444 | -0.006 |
| Other Working Capital
| 0 | 4.284 | -0.966 | 0.578 | -0.314 | 1.79 | -0.77 | -0.903 | 0.441 | 1.002 | 0.023 |
| Other Non Cash Items
| 0 | -2.954 | 2.549 | 0.024 | 17.36 | 12.28 | 0.346 | 0.137 | 0.2 | 1.866 | 0.055 |
| Operating Cash Flow
| -24.71 | -10.799 | -11.712 | -15.134 | -10.764 | -7.039 | -21.911 | -26.901 | -11.043 | -5.433 | -0.195 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -0.008 | -0.05 | 0 | -0.003 | -0.004 | -0.214 | -0.003 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0.008 | -0.001 | 0.18 | 1.525 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 19.998 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -19.998 | 0 | 0 | -0.582 | -0.107 | -7.368 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -0.008 | -0.05 | 0.008 | -0.586 | 0.069 | -6.057 | -0.003 | 0 | 0 | 0 | 0 |
| Financing Activities: | |||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | 10 | 5.151 | 7.416 | 0.509 |
| Common Stock Issued
| -0.048 | -0.08 | 32.25 | 24 | 7.5 | 24.24 | 25.15 | 12.541 | 30.278 | 0.003 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 18.348 | -0.08 | -3.569 | -1.974 | -0.642 | 24.167 | -8.404 | -1.2 | -3.973 | 1.32 | 0 |
| Financing Cash Flow
| 18.3 | -0.08 | 28.681 | 22.026 | 6.858 | 24.167 | 22.392 | 21.341 | 31.456 | 8.736 | 0.509 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | -0.008 | 0.003 | 0.007 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -6.418 | -10.929 | 16.977 | 6.298 | -3.834 | 11.078 | 0.481 | -5.56 | 20.413 | 3.303 | 0.314 |
| Cash At End Of Period
| 16.017 | 22.435 | 33.364 | 16.387 | 10.089 | 13.923 | 18.954 | 18.473 | 24.033 | 3.62 | 0.317 |